Plain-English translation of NCT04758975 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether combining three medications—, , and —can completely eliminate chronic lymphocytic leukemia (a type of blood cancer) in newly diagnosed patients. The study uses special blood tests to check how well the treatment is working and decides whether to continue or stop medication based on those results. The goal is to help patients achieve long-term remission with the shortest possible treatment time.
Current treatments for chronic lymphocytic leukemia work well but often require long-term medication. This trial is exploring whether this three-drug combination can work so effectively that some patients might eventually stop taking medication altogether while staying cancer-free.
You likely qualify if…
You likely don't qualify if…
You would take as a daily pill, starting with a gradual dose increase over the first month, then a steady dose. After six months, (a medication given by infusion) would be added once monthly for six more months. After one year, doctors would test your blood and bone marrow to see if the cancer is completely gone. If it is, you would stop treatment. If not, you would add (another daily pill) and continue until the cancer disappears or for up to two years total. Throughout the trial, you would have regular blood tests and clinic visits to monitor your health and how well the treatment is working.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Italy